Patients deserve care that is individualized, Hernandez said
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Cognizin citicoline, Rhodiolife rhodiola, saffron, PQQ, lion's mane, KSM-66 ashwagandha, and other key ingredients combine to enhance clarity while also promoting calm, allowing you to sustain focus
Many patients choose glutathione treatment for cosmetic enhancement while also benefiting from its broader wellness effects